Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation
Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation
批准号:
8763536
负责人:
Terry van Dyke
金额:
$51.91万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdultAstrocytesAstrocytomaAutomobile DrivingBrainCellsDevelopmentDifferentiation AntigensDiseaseEventGenetically Engineered MouseGlial Fibrillary Acidic ProteinGlioblastomaGoalsHomeostasisHumanIn VitroLarge T AntigenMalignant NeoplasmsN-terminalPTEN genePathway interactionsPopulationPredispositionPreparationProcessProliferatingPropertySolidSpecificityStem cellsTumor Suppressioncancer therapyeffective therapyin vivomouse modelmutantneoplastic cellnerve stem cellnovelprogenitorprogramspromoterresponse to injuryself-renewalstemtumortumor initiationtumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Glioblastoma is the most common human brain malignancy, and as yet there is no effective treatment. Several studies have implicated neural progenitor and stem cells as targets for glioblastoma development. Here we demonstrate a novel mechanism by which differentiated astrocytes can be converted into progenitor state and act as cells of origin in GBM. Using adult inducible HGA GEMMs where Rb tumor suppression (TS) is abrogated along with Kras activation we demonstrate that Rb TS inactivation in adult astrocytes in vitro and in vivo, converts them into progenitor cells generating a pretumorigenic state that is susceptible to GBM progression. Upon Rb TS inactivation, cortical astrocytes dedifferentiated into cells expressing proliferation and progenitor markers while suppressing the expression of differentiation markers. These "dedifferentiated" cells were capable of forming spheres, self renewed and could be experimentally driven into multilineage differentiation. Conversion of astrocytes to progenitor-like cells was required to create susceptibility for the tumor to progress to a higher grade disease by Kras activation. By itself Kras was not sufficient either for tumorigenesis or for induction of progenitor properties. Thus the target cell population may depend on the specificity of astrocytes to stochastic events that arise during homeostasis. Some astrocytes proliferate in response to injury, alteration in Rb network can generate a progenitor population, susceptible for a second hit in the Kras pathway and progression into HGA. This process also provides a mechanism for origination of cancer-initiating cells which can propagate the cancer even after a cancer treatment. With the Rb network known to be altered in majority solid cancers our results may indicate novel mechanism for tumor initiation in a broad spectrum of cancers. Adhikari, A. Sullivan, T, and T. Van Dyke. Abrogation of Rb tumor suppression initiates GBM from differentiated astrocytes by driving a progenitor cell program. In preparation
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models
-
批准号:8552875
-
项目类别:
-
资助金额:$65.22万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma
-
批准号:8552936
-
项目类别:
-
资助金额:$65.22万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Establishing the Preclinical Model for Metastatic Melanoma
-
批准号:8553206
-
项目类别:
-
资助金额:$42.07万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
-
批准号:8349422
-
项目类别:
-
资助金额:$41.4万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Development of ESiPSC approach for non-germline GEM modelling
-
批准号:8349534
-
项目类别:
-
资助金额:$20.7万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Development and validation of preclinical mouse model for serous ovarian cancer
-
批准号:8349495
-
项目类别:
-
资助金额:$144.91万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model
-
批准号:8349382
-
项目类别:
-
资助金额:$29.82万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Mechanisms of Early Stage Mammary Tumorigenesis
-
批准号:8349440
-
项目类别:
-
资助金额:$59.63万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
-
批准号:8938029
-
项目类别:
-
资助金额:$40.49万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Development of ESiPSC approach for non-germline GEM modeling
-
批准号:8938101
-
项目类别:
-
资助金额:$20.24万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
-
批准号:8157726
-
项目类别:
-
资助金额:$88.61万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Development and validation of preclinical mouse model for serous ovarian cancer
-
批准号:8553127
-
项目类别:
-
资助金额:$105.18万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer
-
批准号:8763408
-
项目类别:
-
资助金额:$84.81万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma
-
批准号:8349282
-
项目类别:
-
资助金额:$119.27万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Preclinical Characterization of Drugs in Mouse Model of Lung Cancer
-
批准号:8349406
-
项目类别:
-
资助金额:$124.21万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models
-
批准号:8349218
-
项目类别:
-
资助金额:$89.45万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models
-
批准号:8763259
-
项目类别:
-
资助金额:$51.91万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Pathway Analysis in Mouse Model for Astrocytoma via Systems Biology Approach
-
批准号:8763418
-
项目类别:
-
资助金额:$33.93万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
The Mechanism of Thymic Lymphomagenesis in Genetically Engineered Mouse Model
-
批准号:8763391
-
项目类别:
-
资助金额:$25.96万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
Systems biology study of astrocytomagenesis
-
批准号:8938208
-
项目类别:
-
资助金额:$14.02万
-
财政年份:--
-
负责人:Terry van Dyke
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: